In this issue of Blood, Lichtenstein et al1  report a recurring mutation in NDUFB11, a mitochondrial respiratory complex I–associated protein encoded on the X chromosome, in 5 males with congenital sideroblastic anemia (CSA). The mutation resulted in respiratory insufficiency and loss of complex I stability and activity in patient-derived fibroblasts. This finding corroborates other evidence suggesting that sideroblastic anemia can be caused by dysfunction of the mitochondrial respiratory chain (RC).

Probable mechanism of RC dysfunction causing mitochondrial iron overload. I, II, III, and IV represent multienzyme complexes of the RC. c, cytochrome c; e-, electron(s); Q, coenzyme Q.

Probable mechanism of RC dysfunction causing mitochondrial iron overload. I, II, III, and IV represent multienzyme complexes of the RC. c, cytochrome c; e-, electron(s); Q, coenzyme Q.

Close modal

The first evidence of mitochondrial RC involvement in sideroblastic anemia came from Pearson’s syndrome, a rare congenital disorder characterized by lactic acidosis, pancreatic exocrine insufficiency, and sideroblastic anemia. The disease is caused by large deletions of mitochondrial DNA (mtDNA).2  Because all 13 proteins encoded by the mitochondrial genome are components of the RC, large mtDNA deletions lead to impaired mitochondrial respiration. RC defects can also result from altered mitochondrial transfer RNAs (tRNAs) disturbing mitochondrial protein synthesis. Such a mechanism seems to be involved in CSAs caused by mutation of the mitochondrial tyrosyl-tRNA synthetase gene (YARS2),3  mutation of tRNA nucleotidyl transferase 1 (TRNT1),4  or mutation of pseudouridine synthase 1 (PUS1).5 

Another possible cause of RC malfunction is impaired mitochondrial biogenesis of iron–sulfur clusters (ISCs), because the RC, in particular complex I, contains iron–sulfur proteins that are critical for electron transport. This may partly explain congenital sideroblastic anemia caused by mutation of glutaredoxin 5, which is involved in mitochondrial ISC assembly.6 

The reversible sideroblastic anemia of copper deficiency can also be explained in terms of RC dysfunction, because copper is pivotal to the functioning of RC complex IV (cytochrome c oxidase).

In all these circumstances, the following question arises: how does respiratory insufficiency lead to mitochondrial iron overload? The following mechanism appears plausible (see figure). As the RC normally consumes most of the oxygen that reaches the mitochondrion, a defective RC, by decreasing O2 consumption, will leave more O2 than usual in the mitochondrial matrix. This can lead to oxidation of the incoming iron, which has crossed the inner mitochondrial membrane in the divalent form (ferrous iron, Fe2+) and must remain in the divalent form to be accepted by ferrochelatase for incorporation into protoporphyrin IX to make heme. If surplus oxygen converts Fe2+ to the trivalent form (ferric iron, Fe3+), this “rusted iron” is useless for heme synthesis, because it is rejected by ferrochelatase and will thus accumulate in the mitochondrial matrix.

Does this pathogenetic mechanism also play a role in the most common form of sideroblastic anemia, namely that related to myelodysplastic syndromes (MDS)? Acquired, clonally amplified mutations of mtDNA have been identified in MDS,7  but circumstantial evidence of a causative relation with the sideroblastic phenotype and/or ineffective erythropoiesis has only been provided in a few cases.8,9  Matthes and coworkers confirmed RC dysfunction in a case of CSA with large mtDNA deletion but were unable to find RC dysfunction in 5 patients with refractory anemia with ringed sideroblasts (RARS).10  It is tempting to speculate that acquired mutations (in mtDNA or nuclear DNA) that cause severe RC dysfunction are incompatible with incessant clonal proliferation in MDS and are therefore selected against. In MDS-related sideroblastic anemia, the mechanism should thus be sought outside the RC in most cases. This is in line with the finding that ∼80% of patients with RARS or refractory cytopenia with multilineage dysplasia and ringed sideroblasts carry an acquired mutation of SF3B1, a component of the splicing machinery. Although we know that a wide range of pre–messenger RNAs, including that of the mitochondrial transporter ABCB7, are aberrantly spliced and undergo nonsense-mediated decay, we do not yet understand how this leads to mitochondrial iron overload. Lichtenstein et al have identified an interesting cause of CSA, and future analyses of families with CSA may reveal further defects of the RC. For MDS, however, the riddle of the ring sideroblast remains to be solved.

Conflict-of-interest disclosure: The author declares no competing financial interests.

1
Lichtenstein
 
DA
Crispin
 
AW
Sendamarai
 
AK
et al. 
A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia.
Blood
2016
, vol. 
128
 
15
(pg. 
1913
-
1917
)
2
Rotig
 
A
Colonna
 
M
Bonnefont
 
JP
et al. 
Mitochondrial DNA deletion in Pearson’s marrow/pancreas syndrome.
Lancet
1989
, vol. 
1
 
8643
(pg. 
902
-
903
)
3
Riley
 
LG
Cooper
 
S
Hickey
 
P
et al. 
Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome.
Am J Hum Genet
2010
, vol. 
87
 
1
(pg. 
52
-
59
)
4
Chakraborty
 
PK
Schmitz-Abe
 
K
Kennedy
 
EK
et al. 
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).
Blood
2014
, vol. 
124
 
18
(pg. 
2867
-
2871
)
5
Bykhovskaya
 
Y
Casas
 
K
Mengesha
 
E
Inbal
 
A
Fischel-Ghodsian
 
N
Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA).
Am J Hum Genet
2004
, vol. 
74
 
6
(pg. 
1303
-
1308
)
6
Camaschella
 
C
Campanella
 
A
De Falco
 
L
et al. 
The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload.
Blood
2007
, vol. 
110
 
4
(pg. 
1353
-
1358
)
7
Wulfert
 
M
Küpper
 
AC
Tapprich
 
C
et al. 
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
Exp Hematol
2008
, vol. 
36
 
5
(pg. 
577
-
586
)
8
Gattermann
 
N
Retzlaff
 
S
Wang
 
YL
et al. 
Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia.
Blood
1997
, vol. 
90
 
12
(pg. 
4961
-
4972
)
9
Gattermann
 
N
Wulfert
 
M
Junge
 
B
Germing
 
U
Haas
 
R
Hofhaus
 
G
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome.
Blood
2004
, vol. 
103
 
4
(pg. 
1499
-
1502
)
10
Matthes
 
T
Rustin
 
P
Trachsel
 
H
et al. 
Different pathophysiological mechanisms of intramitochondrial iron accumulation in acquired and congenital sideroblastic anemia caused by mitochondrial DNA deletion.
Eur J Haematol
2006
, vol. 
77
 
2
(pg. 
169
-
174
)
Sign in via your Institution